// App-Quantinova.ai

11045 : Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

Researchers

Presenter

  • Elena Palassini

Principal Investigators

  • Stefano Ferrari

  • Javier Martin Broto

  • Paolo Verderio

  • Antonio Lopez-Pousa

  • Angela Buonadonna

  • Rosalba Miceli

  • Silvia Stacchiotti

  • Angelo Paolo Dei Tos

  • Antonino De Paoli

  • Davide Maria Donati

  • Andres Poveda

  • Vittorio Quagliuolo

  • Alessandro Comandone

  • Stefano Bottelli

  • Piero Picci

  • Paolo Giovanni Casali

  • Alessandro Gronchi

Medical Centers

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Istituto Ortopedico Rizzoli, Bologna, Italy

  • Virgen del Rocio University Hospital, Seville, Spain

  • Istituto Nazionale Tumori, Milano, Italy

  • Hospital De Sant Pau, Barcelona, Spain

  • Dipartimento di Oncologia Medica, Istituto Nazionale Tumori, Aviano, Italy

  • Azienda ULSS 9 Treviso, Treviso, Italy

  • Centro di Riferimento Oncologico, Pordenone, Italy

  • Clinical Area of Gynecologic Oncology, Instituto Valenciano de Oncologia (IVO), Valencia, Spain

  • Istituto Clinico Humanitas, Milan, Italy

  • Ospedale Gradenigo, Pianezza, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Istituto Ortopedico Rizzoli, Bologna, Italy

Locations

  • Spain

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Sarcoma

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • Epirubicin

  • Ifosfamide

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

Phase

  • III

Study Id's

  • NCT01710176

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved